US Stock MarketDetailed Quotes

ATRA Atara Biotherapeutics

  • 10.040
  • -0.390-3.74%
Close Jul 24 16:00 ET
49.24MMarket Cap-189P/E (TTM)

About Atara Biotherapeutics Company

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Company Profile

Company NameAtara Biotherapeutics
Listing DateOct 16, 2014
Issue Price11.00
CEODr. Pascal Touchon, D.V.M.
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2380 Conejo Spectrum Street,Suite 200
CityThousand Oaks
CountryUnited States of America
Zip Code91320

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Pascal Touchon, D.V.M.
  • Director, President and Chief Executive Officer
  • 4.38M
  • Amar Murugan
  • Executive Vice President and Chief Legal Officer
  • 2.31M
  • Eric Hyllengren
  • Executive Vice President, Chief Financial Officer and Principal Accounting Officer
  • --
  • AnhCo Nguyen
  • Executive Vice President, Chief Scientific and Technical Officer
  • 2.28M
  • Jill Henrich
  • Executive Vice President, Global Head Regulatory Affairs and Quality
  • --
  • Dr. Carol G. Gallagher,Pharm.D.
  • Chairman of the Board
  • 260.23K
  • William K. Heiden
  • Independent Director
  • 237.23K
  • Eric L. Dobmeier
  • Independent Director
  • 244.73K
  • Matthew K. Fust
  • Independent Director
  • 239.73K
  • Ameet Mallik
  • Independent Director
  • 219.52K
  • Dr. Maria Grazia Roncarolo, M.D.
  • Independent Director
  • 229.73K


Analyst Rating

No Data

Price Target

No Data

Heat List
Latest Price